World Parkinson Congress Blog

Long-term Effects Of A 6-Month Brisk Walking And Balance Program On Motor Symptoms, Balance And Physical Performance In People With Parkinson Disease

Long-term Effects Of A 6-Month Brisk Walking And Balance Program On Motor Symptoms, Balance And Physical Performance In People With Parkinson Disease

by Margaret KY Mak PhD

Basic ScienceMargaret Mak, PhDAugust 28, 2024Nine, Parkinson's, Walking, Balance, motor progressionComment

Could Mini Antibodies Block Parkinson's Disease Progression?

Could Mini Antibodies Block Parkinson's Disease Progression?

by Anne-Marie Castonguay, PhD

Basic ScienceAnne-Marie Castonguay, PhDAugust 14, 2024Nine, Parkinson's, Monoclonal Antibody, alpha-synucleinComment

National Plan to End Parkinson’s Act Signed into U.S. Law with Historic Global Significance

National Plan to End Parkinson’s Act Signed into U.S. Law with Historic Global Significance

by The Michael J. Fox Foundation

AdvocacyThe Michael J. Fox FoundationJuly 29, 2024Nine, Parkinson's, The Michael J. Fox FoundationComment

Co-pathologies in PD

Co-pathologies in PD

by Jeffrey H. Kordower, PhD

Basic ScienceJeffrey H. Kordower PhDJuly 11, 2024Nine, Parkinson's, Brain, ProteinComment

Unveiling Parkinson's Disease Through The Microscopic Lens

Unveiling Parkinson's Disease Through The Microscopic Lens

by Diana Lázaro, PhD

Basic ScienceDiana Lázaro, PhDJuly 3, 2024Nine, Parkinson's Disease, alpha-synuclein, microscopy, super-resolutionComment

In Your Own Words: Fears and Uncertainties in Parkinson's Disease

In Your Own Words: Fears and Uncertainties in Parkinson's Disease

by Sneha Mantri, MD MS

Clinical ScienceSneha Mantri, MD MSJune 19, 2024Nine, Parkinson's, WPC2023Comment

Talk the Walk: Dual Tasking With Walking And Visual-Verbal Processing

Talk the Walk: Dual Tasking With Walking And Visual-Verbal Processing

by Valerie Carter PT, DPT, NCS, GCS

Clinical ScienceValerie Carter PT, DPT, NCS, GCSJune 5, 2024Nine, Parkinson's, Walking, WPC2023Comment

From Canada to Barcelona: Bringing the Canadian Open Parkinson Network (C-OPN) to the 6th World Parkinson Congress

From Canada to Barcelona: Bringing the Canadian Open Parkinson Network (C-OPN) to the 6th World Parkinson Congress

by Marisa Cressatti, PhD

Advocacy, Clinical ScienceMarisa Cressatti, PhDMay 23, 2024parkinsons, Nine, Atypical Parkinsonism, WPC2023, researchComment

Investigating Pain Catastrophizing To Improve Treatment Of Pain And Psychological Distress in Parkinson’s Disease

Investigating Pain Catastrophizing To Improve Treatment Of Pain And Psychological Distress in Parkinson’s Disease

by Sylvia Zimmers, PhD

Clinical ScienceSylvia Zimmers, PhDMay 9, 2024Parkinson's, WPC2023, Pain, anxiety, Depression, Catastrophizing, NineComment

Creating A Human Brain Model To Study Parkinson’s Disease

Creating A Human Brain Model To Study Parkinson’s Disease

by Beatriz Elena Lucumí Villegas, MD

Basic ScienceBeatriz Elena Lucumí Villegas, MDApril 25, 2024Stem Cells, Parkinson's, Organoids, Assembloids, alpha-synuclein, Nine, WPC2023Comment

How WPC Led Me To Do Research In Women With Parkinson’s

How WPC Led Me To Do Research In Women With Parkinson’s

by Richelle Flanagan

Comprehensive LivingRichelle FlanaganApril 18, 2024Parkinson's, Women, WPC2023, Research, NineComment

Replacing The Loss Of Neurons With Super Resistant Ones In Parkinson’s Disease

Replacing The Loss Of Neurons With Super Resistant Ones In Parkinson’s Disease

by Béatrice Morin, MSc

Basic ScienceBéatrice Morin, MScApril 10, 2024Cell replacement therapy, Immunotherapy, Derived monoclonal antibodies, Parkinson's, WPC2023, NineComment

Dyskinesia and Parkinson’s Disease

Dyskinesia and Parkinson’s Disease

by Tyler Okelberry, MD and Rajesh Pahwa, MD

Clinical ScienceTyler Okelberry, MD and Rajesh Pahwa, MDApril 5, 2024Parkinson's, Dyskinesia, WPC2023, Nine, LevodopaComment

Beyond Color: The Hidden Impact of Neuromelanin In The Brain

Beyond Color: The Hidden Impact of Neuromelanin In The Brain

by Núria Peñuelas, PhD

Basic ScienceNúria Peñuelas, PhDMarch 25, 2024Neuromelanin, Neuronal vulnerability, Preclinical models, Aging, Parkinson's, WPC2023, NineComment

Could Subgrouping Parkinson’s Disease Using Cellular Phenotyping Enable Success at Clinical Trials?

Could Subgrouping Parkinson’s Disease Using Cellular Phenotyping Enable Success at Clinical Trials?

by Toby Burgess PhD Student

Basic ScienceToby Burgess PhD StudentMarch 13, 2024Parkinson, Clinical Trials, Brain, NineComment

Parkinson’s Beats – The Exercise That Makes You Come Back For More

Parkinson’s Beats – The Exercise That Makes You Come Back For More

by Jo Holland and Julie Jones

Comprehensive LivingJo Holland and Julie JonesFebruary 28, 2024Parkinson, Excercise, exercise motivation, Nine Comments

Pre-Clinical Models of Levodopa - Induced Dyskinesia

Pre-Clinical Models of Levodopa - Induced Dyskinesia

by Philippe Huot, MD, PhD

Clinical SciencePhilippe Huot, MD, PhDFebruary 14, 2024Parkinson's, Levodopa, dysphagia, Nine Comment

Unveiling the Impact of Apathy on Parkinson's Disease: A Gendered Perspective

Unveiling the Impact of Apathy on Parkinson's Disease: A Gendered Perspective

by Ana Jimena Hernández-Medrano, MD, MSc-candidate

Comprehensive LivingAna Jimena Hernández-Medrano, MDJanuary 31, 2024Parkinson's Disease, Apathy, Gender equity, Quality of Life, NineComment

Impact of Alpha-Synuclein Pathology on the Blood-Brain Barrier

Impact of Alpha-Synuclein Pathology on the Blood-Brain Barrier

by Kristina Lau, PhD student

Basic ScienceKristina Lau, PhD studentJanuary 17, 2024Brain capillaries, Endothelial activation, Alpha-synuclein pathology, Transporter proteins, Vessel density, Parkinson's, NineComment

Zoom Into Different Flavors of Dopaminergic Neurons

Zoom Into Different Flavors of Dopaminergic Neurons

by Kawai Lee, PhD student

Basic ScienceKawai LeeJanuary 3, 2024Parkinson's, Neurons, Nine Comment